Rank | Gene Set | Z-score |
---|---|---|
1 | type I interferon signaling pathway (GO:0060337) | 6.06735231 |
2 | cellular response to type I interferon (GO:0071357) | 6.06735231 |
3 | response to type I interferon (GO:0034340) | 5.97530317 |
4 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.15698034 |
5 | regulation of chronic inflammatory response (GO:0002676) | 4.91006953 |
6 | negative regulation of viral genome replication (GO:0045071) | 4.79344210 |
7 | regulation of interferon-alpha production (GO:0032647) | 4.65341157 |
8 | negative regulation of interleukin-12 production (GO:0032695) | 4.50135208 |
9 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.39920805 |
10 | immunoglobulin mediated immune response (GO:0016064) | 4.33944635 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 4.19844116 |
12 | positive regulation of type 2 immune response (GO:0002830) | 4.13754768 |
13 | response to interferon-beta (GO:0035456) | 4.12235152 |
14 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.06130399 |
15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.02791700 |
16 | response to interferon-alpha (GO:0035455) | 3.98512500 |
17 | macrophage activation involved in immune response (GO:0002281) | 3.93127407 |
18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91826010 |
19 | regulation of T cell tolerance induction (GO:0002664) | 3.86690535 |
20 | response to peptidoglycan (GO:0032494) | 3.85176445 |
21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81832518 |
22 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.81743189 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80590885 |
24 | defense response to protozoan (GO:0042832) | 3.79520050 |
25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.70558297 |
26 | myeloid dendritic cell differentiation (GO:0043011) | 3.69698621 |
27 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.68136173 |
28 | T-helper 1 type immune response (GO:0042088) | 3.65886589 |
29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58073918 |
30 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.57671973 |
31 | negative regulation of cell killing (GO:0031342) | 3.56876695 |
32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56876695 |
33 | cellular response to interferon-alpha (GO:0035457) | 3.53882459 |
34 | cellular response to interferon-gamma (GO:0071346) | 3.53682328 |
35 | response to protozoan (GO:0001562) | 3.53297859 |
36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51243179 |
37 | B cell mediated immunity (GO:0019724) | 3.50430342 |
38 | detection of other organism (GO:0098543) | 3.47470968 |
39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46451228 |
40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46451228 |
41 | modulation by symbiont of host immune response (GO:0052553) | 3.46451228 |
42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46451228 |
43 | modulation by symbiont of host defense response (GO:0052031) | 3.46451228 |
44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46451228 |
45 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.45151284 |
46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.44694634 |
47 | response to interferon-gamma (GO:0034341) | 3.40596518 |
48 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.39949457 |
49 | germinal center formation (GO:0002467) | 3.39604151 |
50 | regulation of antigen processing and presentation (GO:0002577) | 3.39446961 |
51 | positive regulation of interferon-beta production (GO:0032728) | 3.37595543 |
52 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.32358184 |
53 | detection of bacterium (GO:0016045) | 3.32145041 |
54 | regulation of type 2 immune response (GO:0002828) | 3.32090813 |
55 | NIK/NF-kappaB signaling (GO:0038061) | 3.31243793 |
56 | regulation of viral genome replication (GO:0045069) | 3.30367389 |
57 | regulation of tolerance induction (GO:0002643) | 3.29603549 |
58 | defense response to virus (GO:0051607) | 3.28908756 |
59 | positive regulation of defense response to virus by host (GO:0002230) | 3.28542742 |
60 | myeloid dendritic cell activation (GO:0001773) | 3.26571543 |
61 | regulation of vitamin metabolic process (GO:0030656) | 3.25553625 |
62 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.24202009 |
63 | detection of molecule of bacterial origin (GO:0032490) | 3.23611055 |
64 | regulation of interleukin-12 production (GO:0032655) | 3.22375233 |
65 | regulation of regulatory T cell differentiation (GO:0045589) | 3.21517104 |
66 | negative regulation of viral process (GO:0048525) | 3.19718684 |
67 | regulation of T-helper cell differentiation (GO:0045622) | 3.19631449 |
68 | regulation of RIG-I signaling pathway (GO:0039535) | 3.17414432 |
69 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.12135840 |
70 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.11300883 |
71 | interferon-gamma secretion (GO:0072643) | 3.10482131 |
72 | detection of external biotic stimulus (GO:0098581) | 3.06925851 |
73 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.06486461 |
74 | cellular response to interferon-beta (GO:0035458) | 3.05815192 |
75 | T cell migration (GO:0072678) | 3.05015626 |
76 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01367009 |
77 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.00803459 |
78 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.00386163 |
79 | neutrophil activation involved in immune response (GO:0002283) | 2.99459433 |
80 | lymphocyte chemotaxis (GO:0048247) | 2.99042377 |
81 | positive regulation of interleukin-12 production (GO:0032735) | 2.97046670 |
82 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.95664722 |
83 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94646204 |
84 | regulation of mononuclear cell migration (GO:0071675) | 2.93288050 |
85 | positive regulation of tolerance induction (GO:0002645) | 2.92462240 |
86 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.92303087 |
87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92078288 |
88 | dendritic cell differentiation (GO:0097028) | 2.91710760 |
89 | granulocyte activation (GO:0036230) | 2.91187184 |
90 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.86946456 |
91 | regulation of T-helper 1 type immune response (GO:0002825) | 2.86856396 |
92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86727157 |
93 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.86348244 |
94 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.86152650 |
95 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.86104408 |
96 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.85680900 |
97 | eosinophil chemotaxis (GO:0048245) | 2.85414799 |
98 | JAK-STAT cascade (GO:0007259) | 2.84845826 |
99 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.84680998 |
100 | negative regulation of T cell mediated immunity (GO:0002710) | 2.80410726 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.55680202 |
2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.40231098 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.83192577 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.23694905 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.67916446 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.38223992 |
7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.63193978 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.52171404 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.47728408 |
10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.01461349 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.95389513 |
12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.92809889 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91531716 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69415619 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66556504 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24056074 |
17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23645859 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.16597114 |
19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.14399055 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05476112 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97087138 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 1.92807759 |
23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.91080989 |
24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79115222 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73908731 |
26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62048330 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 1.55387780 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54077268 |
29 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51599501 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49792214 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48708938 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 1.46971164 |
33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46962361 |
34 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.42970713 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41882352 |
36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40635318 |
37 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40507969 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39934415 |
39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36671122 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35782485 |
41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34728240 |
42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33593053 |
43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32085992 |
44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28067834 |
45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27184826 |
46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26552784 |
47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26014281 |
48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18844174 |
49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12459383 |
50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12211135 |
51 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10875065 |
52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07969857 |
53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06939764 |
54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05061989 |
55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04229525 |
56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03547706 |
57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03220486 |
58 | MAF_26560356_Chip-Seq_TH2_Human | 1.02462968 |
59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01113558 |
60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00560900 |
61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99426815 |
62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97354046 |
63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.96092942 |
64 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95808713 |
65 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95619626 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90048996 |
67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88441905 |
68 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88159818 |
69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86217652 |
70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86070918 |
71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85997459 |
72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82553884 |
73 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80732847 |
74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80714991 |
75 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80079253 |
76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.75358426 |
77 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73916084 |
78 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72954318 |
79 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.71559510 |
80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71553479 |
81 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.70599219 |
82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68904609 |
83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68653175 |
84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.68532652 |
85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.67652330 |
86 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.67565723 |
87 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67331407 |
88 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.64970907 |
89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.64290384 |
90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.64052200 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.62967374 |
92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62908516 |
93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.59577385 |
94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.58537768 |
95 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.58129829 |
96 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.56857785 |
97 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.56607759 |
98 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56495685 |
99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.56252011 |
100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.55437881 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.57999673 |
2 | MP0003303_peritoneal_inflammation | 4.57086034 |
3 | MP0001835_abnormal_antigen_presentation | 3.91514777 |
4 | MP0009785_altered_susceptibility_to | 3.90189893 |
5 | MP0006082_CNS_inflammation | 3.63537695 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.55915605 |
7 | MP0005671_abnormal_response_to | 3.33169528 |
8 | MP0003436_decreased_susceptibility_to | 3.30679678 |
9 | MP0002138_abnormal_hepatobiliary_system | 3.02761009 |
10 | MP0001790_abnormal_immune_system | 3.00250943 |
11 | MP0005387_immune_system_phenotype | 3.00250943 |
12 | MP0005000_abnormal_immune_tolerance | 2.94303408 |
13 | MP0005025_abnormal_response_to | 2.88281649 |
14 | MP0001800_abnormal_humoral_immune | 2.74392749 |
15 | MP0002723_abnormal_immune_serum | 2.56438571 |
16 | MP0002419_abnormal_innate_immunity | 2.47933696 |
17 | MP0002452_abnormal_antigen_presenting | 2.42606689 |
18 | MP0004510_myositis | 2.38583816 |
19 | MP0000685_abnormal_immune_system | 2.37865432 |
20 | MP0003300_gastrointestinal_ulcer | 2.31854142 |
21 | MP0010155_abnormal_intestine_physiology | 2.28536845 |
22 | MP0009764_decreased_sensitivity_to | 2.15021886 |
23 | MP0001819_abnormal_immune_cell | 2.11914002 |
24 | MP0002420_abnormal_adaptive_immunity | 2.09580212 |
25 | MP0004947_skin_inflammation | 2.06631951 |
26 | MP0001845_abnormal_inflammatory_respons | 2.02985396 |
27 | MP0001533_abnormal_skeleton_physiology | 2.00506475 |
28 | MP0009333_abnormal_splenocyte_physiolog | 1.91661076 |
29 | MP0008469_abnormal_protein_level | 1.82096929 |
30 | MP0003806_abnormal_nucleotide_metabolis | 1.79252324 |
31 | MP0002139_abnormal_hepatobiliary_system | 1.77953928 |
32 | MP0005451_abnormal_body_composition | 1.76342795 |
33 | MP0005058_abnormal_lysosome_morphology | 1.73311695 |
34 | MP0003075_altered_response_to | 1.68357275 |
35 | MP0002405_respiratory_system_inflammati | 1.63589343 |
36 | MP0000716_abnormal_immune_system | 1.59342316 |
37 | MP0005310_abnormal_salivary_gland | 1.55905398 |
38 | MP0001853_heart_inflammation | 1.45360183 |
39 | MP0002332_abnormal_exercise_endurance | 1.44732001 |
40 | MP0003195_calcinosis | 1.44149705 |
41 | MP0008004_abnormal_stomach_pH | 1.43603084 |
42 | MP0002398_abnormal_bone_marrow | 1.43275169 |
43 | MP0003763_abnormal_thymus_physiology | 1.40855695 |
44 | MP0003172_abnormal_lysosome_physiology | 1.39422754 |
45 | MP0002254_reproductive_system_inflammat | 1.37799635 |
46 | MP0006054_spinal_hemorrhage | 1.37428398 |
47 | MP0003183_abnormal_peptide_metabolism | 1.29071865 |
48 | MP0009278_abnormal_bone_marrow | 1.28716854 |
49 | MP0003448_altered_tumor_morphology | 1.28389985 |
50 | MP0000343_altered_response_to | 1.27565648 |
51 | MP0005166_decreased_susceptibility_to | 1.26891323 |
52 | MP0009840_abnormal_foam_cell | 1.26255539 |
53 | MP0003191_abnormal_cellular_cholesterol | 1.25319513 |
54 | MP0000858_altered_metastatic_potential | 1.19615357 |
55 | MP0002429_abnormal_blood_cell | 1.18270983 |
56 | MP0001873_stomach_inflammation | 1.16761487 |
57 | MP0003453_abnormal_keratinocyte_physiol | 1.11419923 |
58 | MP0001545_abnormal_hematopoietic_system | 1.10576020 |
59 | MP0005397_hematopoietic_system_phenotyp | 1.10576020 |
60 | MP0000689_abnormal_spleen_morphology | 1.10445163 |
61 | MP0005464_abnormal_platelet_physiology | 1.09895007 |
62 | MP0002722_abnormal_immune_system | 1.06869916 |
63 | MP0005164_abnormal_response_to | 1.06445367 |
64 | MP0008260_abnormal_autophagy | 1.06203050 |
65 | MP0009763_increased_sensitivity_to | 1.03925770 |
66 | MP0002998_abnormal_bone_remodeling | 1.03669725 |
67 | MP0002277_abnormal_respiratory_mucosa | 0.98722600 |
68 | MP0003866_abnormal_defecation | 0.97425283 |
69 | MP0004883_abnormal_blood_vessel | 0.91707393 |
70 | MP0001663_abnormal_digestive_system | 0.85167113 |
71 | MP0000604_amyloidosis | 0.83029377 |
72 | MP0009765_abnormal_xenobiotic_induced | 0.79858765 |
73 | MP0005390_skeleton_phenotype | 0.79839988 |
74 | MP0005167_abnormal_blood-brain_barrier | 0.73938465 |
75 | MP0002166_altered_tumor_susceptibility | 0.72624745 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.71203353 |
77 | MP0001851_eye_inflammation | 0.69148614 |
78 | MP0002006_tumorigenesis | 0.68462058 |
79 | MP0003690_abnormal_glial_cell | 0.68437316 |
80 | MP0003091_abnormal_cell_migration | 0.68327925 |
81 | MP0001501_abnormal_sleep_pattern | 0.68069773 |
82 | MP0005319_abnormal_enzyme/_coenzyme | 0.67824264 |
83 | MP0000490_abnormal_crypts_of | 0.67592430 |
84 | MP0002933_joint_inflammation | 0.66549947 |
85 | MP0005165_increased_susceptibility_to | 0.66358978 |
86 | MP0000465_gastrointestinal_hemorrhage | 0.66144128 |
87 | MP0000920_abnormal_myelination | 0.65744146 |
88 | MP0001542_abnormal_bone_strength | 0.65404173 |
89 | MP0008874_decreased_physiological_sensi | 0.61930776 |
90 | MP0000703_abnormal_thymus_morphology | 0.61044579 |
91 | MP0000249_abnormal_blood_vessel | 0.60289993 |
92 | MP0002693_abnormal_pancreas_physiology | 0.59079344 |
93 | MP0003045_fibrosis | 0.59064288 |
94 | MP0005365_abnormal_bile_salt | 0.56914072 |
95 | MP0000609_abnormal_liver_physiology | 0.54173792 |
96 | MP0005266_abnormal_metabolism | 0.53987852 |
97 | MP0009643_abnormal_urine_homeostasis | 0.52032469 |
98 | MP0005376_homeostasis/metabolism_phenot | 0.51291778 |
99 | MP0005535_abnormal_body_temperature | 0.49932626 |
100 | MP0003795_abnormal_bone_structure | 0.49325018 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Retrobulbar optic neuritis (HP:0100654) | 6.55986724 |
2 | Optic neuritis (HP:0100653) | 6.55986724 |
3 | Orchitis (HP:0100796) | 6.38138668 |
4 | Myositis (HP:0100614) | 5.77724642 |
5 | Stomatitis (HP:0010280) | 5.34907005 |
6 | Keratoconjunctivitis sicca (HP:0001097) | 4.61270938 |
7 | Eczematoid dermatitis (HP:0000976) | 4.43182097 |
8 | Recurrent bacterial skin infections (HP:0005406) | 4.37312736 |
9 | Abnormality of macrophages (HP:0004311) | 4.35227480 |
10 | Keratoconjunctivitis (HP:0001096) | 4.27586543 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.11210226 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.10824626 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.10824626 |
14 | Abnormality of glycolipid metabolism (HP:0010969) | 4.10824626 |
15 | Recurrent abscess formation (HP:0002722) | 4.08188055 |
16 | Vasculitis (HP:0002633) | 3.89319403 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.83495369 |
18 | Increased IgM level (HP:0003496) | 3.82380985 |
19 | Pulmonary infiltrates (HP:0002113) | 3.82274531 |
20 | Systemic lupus erythematosus (HP:0002725) | 3.76494950 |
21 | Gangrene (HP:0100758) | 3.66420333 |
22 | Autoimmune hemolytic anemia (HP:0001890) | 3.63597957 |
23 | Hemoptysis (HP:0002105) | 3.52121013 |
24 | Gastrointestinal infarctions (HP:0005244) | 3.47155321 |
25 | Abnormality of T cell number (HP:0011839) | 3.39617284 |
26 | Encephalitis (HP:0002383) | 3.36355165 |
27 | T lymphocytopenia (HP:0005403) | 3.31836637 |
28 | Recurrent fungal infections (HP:0002841) | 3.31539920 |
29 | Meningitis (HP:0001287) | 3.16027645 |
30 | Hypergammaglobulinemia (HP:0010702) | 3.15008246 |
31 | Recurrent viral infections (HP:0004429) | 3.09058192 |
32 | Loss of speech (HP:0002371) | 3.01648649 |
33 | Recurrent skin infections (HP:0001581) | 3.00592574 |
34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98333510 |
35 | Arterial thrombosis (HP:0004420) | 2.98238874 |
36 | Vacuolated lymphocytes (HP:0001922) | 2.95517622 |
37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.94552289 |
38 | Autoimmune thrombocytopenia (HP:0001973) | 2.92516355 |
39 | Anorexia (HP:0002039) | 2.86501466 |
40 | Abnormality of the pleura (HP:0002103) | 2.79023849 |
41 | Pulmonary embolism (HP:0002204) | 2.78966429 |
42 | Joint swelling (HP:0001386) | 2.77984545 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75491334 |
44 | Obstructive lung disease (HP:0006536) | 2.75491334 |
45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.72210217 |
46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.72210217 |
47 | Recurrent bronchitis (HP:0002837) | 2.69588071 |
48 | Abnormality of B cell number (HP:0010975) | 2.68096206 |
49 | Polyneuropathy (HP:0001271) | 2.62527302 |
50 | Chronic otitis media (HP:0000389) | 2.59883924 |
51 | Chronic diarrhea (HP:0002028) | 2.56559245 |
52 | Urticaria (HP:0001025) | 2.55542759 |
53 | Keratitis (HP:0000491) | 2.54605205 |
54 | Disinhibition (HP:0000734) | 2.53775803 |
55 | Malnutrition (HP:0004395) | 2.52464561 |
56 | Abnormality of the pericardium (HP:0001697) | 2.48824132 |
57 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.46281886 |
58 | Increased IgE level (HP:0003212) | 2.42706531 |
59 | Increased cerebral lipofuscin (HP:0011813) | 2.42208816 |
60 | Hematochezia (HP:0002573) | 2.39752566 |
61 | Dysostosis multiplex (HP:0000943) | 2.39439909 |
62 | Abnormality of T cells (HP:0002843) | 2.39140014 |
63 | B lymphocytopenia (HP:0010976) | 2.38212810 |
64 | Leukocytosis (HP:0001974) | 2.37955443 |
65 | Parakeratosis (HP:0001036) | 2.37368235 |
66 | Interstitial pulmonary disease (HP:0006530) | 2.36247701 |
67 | Gingivitis (HP:0000230) | 2.31420904 |
68 | IgA deficiency (HP:0002720) | 2.29180026 |
69 | Eosinophilia (HP:0001880) | 2.27674325 |
70 | Glomerulopathy (HP:0100820) | 2.26693209 |
71 | Episodic fever (HP:0001954) | 2.25949090 |
72 | Inflammation of the large intestine (HP:0002037) | 2.23948264 |
73 | Chest pain (HP:0100749) | 2.22401642 |
74 | Abnormality of the endocardium (HP:0004306) | 2.21397719 |
75 | Progressive neurologic deterioration (HP:0002344) | 2.20232296 |
76 | Granulocytopenia (HP:0001913) | 2.20148932 |
77 | IgG deficiency (HP:0004315) | 2.16751501 |
78 | Glomerulonephritis (HP:0000099) | 2.15503752 |
79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13912697 |
80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13912697 |
81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13912697 |
82 | Pustule (HP:0200039) | 2.11896807 |
83 | Vertigo (HP:0002321) | 2.11271432 |
84 | Acne (HP:0001061) | 2.10284972 |
85 | Gastrointestinal inflammation (HP:0004386) | 2.08017755 |
86 | Increased CSF protein (HP:0002922) | 2.04779563 |
87 | Arthralgia (HP:0002829) | 2.03130445 |
88 | Nasal polyposis (HP:0100582) | 2.02357832 |
89 | Gastrointestinal stroma tumor (HP:0100723) | 2.02336666 |
90 | Amyloidosis (HP:0011034) | 2.01017372 |
91 | Increased serum ferritin (HP:0003281) | 2.00497415 |
92 | Peritonitis (HP:0002586) | 1.98330795 |
93 | Recurrent pneumonia (HP:0006532) | 1.97124347 |
94 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94316300 |
95 | Mucopolysacchariduria (HP:0008155) | 1.94316300 |
96 | Stomach cancer (HP:0012126) | 1.94287326 |
97 | Basal ganglia calcification (HP:0002135) | 1.92494986 |
98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92048175 |
99 | Muscle fibrillation (HP:0010546) | 1.91212909 |
100 | Abnormality of the prostate (HP:0008775) | 1.90129995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TYK2 | 3.69772167 |
2 | BLK | 3.67702738 |
3 | TXK | 3.39461088 |
4 | RIPK4 | 3.05738423 |
5 | IRAK4 | 2.92862247 |
6 | IKBKE | 2.92180254 |
7 | BMPR1B | 2.87764572 |
8 | JAK3 | 2.86726250 |
9 | MAP4K1 | 2.85855771 |
10 | TBK1 | 2.84807954 |
11 | GRK7 | 2.83193833 |
12 | MAP3K14 | 2.79349760 |
13 | IRAK3 | 2.71806313 |
14 | JAK1 | 2.28601740 |
15 | MATK | 2.27855007 |
16 | RIPK1 | 2.27116166 |
17 | CSK | 1.93939293 |
18 | CDK8 | 1.88433417 |
19 | IRAK1 | 1.86949583 |
20 | IKBKB | 1.86118572 |
21 | ERN1 | 1.78749921 |
22 | ZAP70 | 1.77870915 |
23 | TAOK2 | 1.71946252 |
24 | TGFBR1 | 1.67811657 |
25 | BMPR2 | 1.65180660 |
26 | FGFR4 | 1.63163380 |
27 | FGR | 1.58138692 |
28 | TAOK1 | 1.45869272 |
29 | KIT | 1.44580134 |
30 | JAK2 | 1.44196592 |
31 | PIM2 | 1.42278069 |
32 | PRPF4B | 1.40792248 |
33 | SIK3 | 1.39601352 |
34 | MAP3K3 | 1.33827280 |
35 | EPHA3 | 1.32676017 |
36 | SYK | 1.30317544 |
37 | ADRBK2 | 1.29286264 |
38 | LYN | 1.28248483 |
39 | DDR2 | 1.23224627 |
40 | MAP2K6 | 1.21620919 |
41 | MAP3K11 | 1.18237317 |
42 | LCK | 1.16994697 |
43 | FGFR3 | 1.06656516 |
44 | CHUK | 1.06613092 |
45 | TGFBR2 | 1.06145138 |
46 | BTK | 1.03449074 |
47 | ACVR1B | 0.98240663 |
48 | MAP2K3 | 0.95365651 |
49 | CDC42BPA | 0.94157939 |
50 | NME2 | 0.93480636 |
51 | EPHB1 | 0.93051103 |
52 | TEC | 0.91694893 |
53 | MOS | 0.90109610 |
54 | ITK | 0.87704689 |
55 | STK24 | 0.85691862 |
56 | HCK | 0.82942457 |
57 | MAP3K1 | 0.81509896 |
58 | CLK1 | 0.81199030 |
59 | IRAK2 | 0.80258654 |
60 | STK10 | 0.79227000 |
61 | TNK2 | 0.76686015 |
62 | CSF1R | 0.72336819 |
63 | DYRK3 | 0.71071694 |
64 | CDK9 | 0.69615658 |
65 | MARK3 | 0.67025252 |
66 | MAP3K5 | 0.67005773 |
67 | FES | 0.62245522 |
68 | HIPK2 | 0.59567429 |
69 | PKN1 | 0.58683047 |
70 | PIM1 | 0.56521388 |
71 | PRKCQ | 0.55558222 |
72 | MAPKAPK2 | 0.49632020 |
73 | TAOK3 | 0.41608072 |
74 | FYN | 0.39912307 |
75 | MAP3K13 | 0.39541357 |
76 | PRKCD | 0.35430741 |
77 | GRK6 | 0.34116433 |
78 | EGFR | 0.31857657 |
79 | DAPK1 | 0.30941502 |
80 | RPS6KA4 | 0.30677035 |
81 | PDK1 | 0.29772220 |
82 | TESK2 | 0.29373587 |
83 | ABL1 | 0.27886306 |
84 | MAPK7 | 0.27855860 |
85 | YES1 | 0.26358388 |
86 | EIF2AK2 | 0.25868344 |
87 | MAPKAPK3 | 0.24753789 |
88 | DAPK2 | 0.23673314 |
89 | STK38 | 0.22531549 |
90 | DAPK3 | 0.22386393 |
91 | MAP4K2 | 0.20894482 |
92 | RPS6KA5 | 0.20070044 |
93 | IGF1R | 0.19225030 |
94 | INSR | 0.19082894 |
95 | GRK5 | 0.18946754 |
96 | TLK1 | 0.18760423 |
97 | MAPK11 | 0.17482760 |
98 | TYRO3 | 0.15771379 |
99 | BCR | 0.14969206 |
100 | CDK6 | 0.14130467 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.63015373 |
2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.13606613 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.09026641 |
4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.91554199 |
5 | Asthma_Homo sapiens_hsa05310 | 2.91289668 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80909420 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71359178 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70511824 |
9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.61490326 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.58991460 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.51493911 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.44695841 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.38321009 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37380963 |
15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.29366836 |
16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.22430554 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18573204 |
18 | Measles_Homo sapiens_hsa05162 | 2.10787108 |
19 | Influenza A_Homo sapiens_hsa05164 | 2.09498843 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00557190 |
21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.97430743 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.92091412 |
23 | Malaria_Homo sapiens_hsa05144 | 1.88203114 |
24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83855298 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81300514 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79344204 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.74323581 |
28 | Pertussis_Homo sapiens_hsa05133 | 1.72682786 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.71280977 |
30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70606885 |
31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.63999298 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58359069 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54037031 |
34 | Hepatitis C_Homo sapiens_hsa05160 | 1.52407769 |
35 | Lysosome_Homo sapiens_hsa04142 | 1.28208182 |
36 | Salmonella infection_Homo sapiens_hsa05132 | 1.25884823 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25653976 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24189259 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18556313 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.08261885 |
41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07234832 |
42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04960602 |
43 | Phagosome_Homo sapiens_hsa04145 | 1.02647532 |
44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93168278 |
45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93146832 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87155746 |
47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84902747 |
48 | Apoptosis_Homo sapiens_hsa04210 | 0.83530489 |
49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80287925 |
50 | Shigellosis_Homo sapiens_hsa05131 | 0.79143158 |
51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77607703 |
52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74270762 |
53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73402973 |
54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67911839 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67171684 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56636100 |
57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55918142 |
58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55614147 |
59 | Prion diseases_Homo sapiens_hsa05020 | 0.53395049 |
60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51293564 |
61 | Amoebiasis_Homo sapiens_hsa05146 | 0.50852102 |
62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48623533 |
63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45606280 |
64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44528486 |
65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42535092 |
66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42080739 |
67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38858051 |
68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36650114 |
69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35228197 |
70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33959137 |
71 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33846616 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33846155 |
73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32901488 |
74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31586079 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31373385 |
76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30680096 |
77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29586478 |
78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.27395233 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26463861 |
80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23609157 |
81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23375361 |
82 | Endocytosis_Homo sapiens_hsa04144 | 0.23272790 |
83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23024395 |
84 | Bladder cancer_Homo sapiens_hsa05219 | 0.20458171 |
85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19435377 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18882167 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18550372 |
88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.15526287 |
89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.14687699 |
90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14122827 |
91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13809105 |
92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12704860 |
93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12549648 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.12268181 |
95 | Mineral absorption_Homo sapiens_hsa04978 | 0.11236959 |
96 | Platelet activation_Homo sapiens_hsa04611 | 0.06242383 |
97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.06145220 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.05781498 |
99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.05695313 |
100 | Peroxisome_Homo sapiens_hsa04146 | 0.04065211 |